Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03897257 · ClinicalTrials.gov registry record · Phase 2
A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis
A Phase 2 study, sponsored by Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 240
- Enrollment target
NCT03897257 is a Phase 2 study that has completed, run by Therapeutics. The registered enrollment target is 240 participants.
The verdict
NCT03897257, a Phase 2 study, has completed, sponsored by Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 240 participants
- Enrollment target
Study Summary
The study is being done to determine and compare the safety and effectiveness of an investigational combination therapy (low and high concentrations) versus mono-therapy (low and high concentrations) or mono-therapy (fixed concentration) in subjects with moccasin type tinea pedis.
Interventions
- DRUG UHE-103A1 cream
- DRUG UHE-103A2 cream
- DRUG UHE-103B cream
- DRUG UHE-103A1B cream
- DRUG UHE-103A2B cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2019-03-15 |
| Est. Completion | 2020-05-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03897257
The ClinicalTrials.gov registry entry for NCT03897257 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Therapeutics, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which UHE-103A1 cream is the first listed.
NCT03897257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03897257 about?
NCT03897257 is a clinical study titled "A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis". The study is being done to determine and compare the safety and effectiveness of an investigational combination therapy (low and high concentrations) versus mono-therapy (low and high concentrations) or mono-therapy (fixed concentration) in subjects with moccasin type tinea pedis.
What is the current status of trial NCT03897257?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2019-03-15. Estimated completion is 2020-05-05.
What interventions are being tested in trial NCT03897257?
The interventions under investigation include: UHE-103A1 cream (DRUG), UHE-103A2 cream (DRUG), UHE-103B cream (DRUG), UHE-103A1B cream (DRUG), UHE-103A2B cream (DRUG).
Who is sponsoring clinical trial NCT03897257?
This trial is sponsored by Therapeutics, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.